Development of an HPV 16 mRNA Based Therapeutic Vaccine Overcoming High Grade HPV Infections

Time: 4:15 pm
day: Conference Day One


  • Preclinical data indicating efficacy of the vaccine in inducing immune response and reducing tumor growth
  • Future directions and potential applications for mRNA-based therapeutic vaccines in HPV treatment and beyond